Reduced cancer-independent life expectancy in head, neck cancer

June 27, 2017

(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

Sean T. Massa, M.D., from St. Louis University, and colleagues calculated and years of life lost (YLL) for patients with head and neck cancer, referenced to the .

The researchers found that patients with head and neck cancer had cancer-independent life expectancy that was 6.5 years shorter than expected. Black race, stage IV, Medicaid, and previous marriage were associated with the greatest hazard (hazard ratios, 1.23, 1.60, 1.55, and 1.49, respectively) and impact of other-cause mortality (YLL, 8.55, 7.92, 12.9, and 11.4, respectively).

"Patients with head and lives are foreshortened independent of their cancer diagnosis necessitating management of noncancer mortality to maximize overall survival," the authors write.

Explore further: More side effects with CRT plus metformin in head, neck cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

More side effects with CRT plus metformin in head, neck cancer

May 7, 2017
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...

Metformin linked to lower risk of head, neck cancer

September 9, 2015
(HealthDay)—Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in the September issue of Head & Neck.

Racial disparity in head and neck cancer outcomes

April 19, 2013
(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in JAMA Otolaryngology-Head ...

High CVD risk in patients with head, neck squamous cell cancer

February 2, 2017
(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published ...

Geographic variation in HPV oropharyngeal cancer prevalence

January 15, 2016
(HealthDay)—There is geographic variation in the proportion of head and neck cancers attributable to human papillomavirus (HPV), according to a study published online Jan. 8 in Head & Neck.

Neuromuscular stimulation doesn't aid dysphagia patients

October 23, 2015
(HealthDay)—Neuromuscular electrical stimulation (NMES) does not add benefit to traditional swallow exercises for patients experiencing dysphagia after treatment for head and neck cancer, according to a study published ...

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

NEJM reports positive results for larotrectinib against TRK-fusion cancer

February 22, 2018
In 2013, the labs of University of Colorado Cancer Center investigator Robert C. Doebele, MD, PhD, and Dana-Farber Cancer Institute investigator Pasi A. Jänne, MD, PhD reported in Nature Medicine the presence of TRK gene ...

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.